Ectodysplasin-A2 Induces Dickkopf 1 Expression in Human Balding Dermal Papilla Cells Overexpressing the Ectodysplasin A2 Receptor

    Mi Hee Kwack, Mee Sook Jun, Young Kwan Sung, Jung Chul Kim, Moon Kyu Kim
    Image of study
    TLDR A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.
    The study explored the connection between ectodysplasin-A2 (EDA-A2) and its receptor (EDA2R) with androgenetic alopecia (AGA), a prevalent type of hair loss. It was found that EDA2R is more highly expressed in balding dermal papilla cells of AGA patients compared to non-balding cells. EDA-A2 was shown to increase the expression of dickkopf 1 (DKK-1), which is an inducer of the hair follicle regression phase and known to inhibit hair growth. The increase in DKK-1 was observed at both mRNA and protein levels. Additionally, the study demonstrated that blocking DKK-1 could reverse EDA-A2-induced apoptosis in hair follicle cells, suggesting that targeting the EDA-A2/EDA2R signaling pathway might be an effective strategy for AGA treatment. The number of participants or samples used in the study was not mentioned in the summary.
    Discuss this study in the Community →

    Research cited in this study

    12 / 12 results

    Related Community Posts Join

    1 / 1 results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  44 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

    Related Research

    7 / 7 results